Management of benign prostate hyperplasia (BPH) by combinatorial approach using alpha-1-adrenergic antagonists and 5-alpha-reductase inhibitors
Osama A. Zitoun, Abdulrahman M. Farhat, Mohamed A. Mohamed, Mohammad Ramadan Hazza Hamad, Beatrice Aramini, Khawaja Husnain Haider
Topics & Concepts
MedicineCombination therapyLower urinary tract symptomsUrologyProstateRandomized controlled trialInternational Prostate Symptom ScoreInternal medicineBenign prostatic hyperplasia (BPH)HyperplasiaAlpha (finance)Clinical trial5 Alpha-Reductase InhibitorOncologySurgeryPatient satisfactionFinasterideConstruct validityCancerUrinary Bladder and Prostate ResearchHormonal and reproductive studiesProstate Cancer Diagnosis and Treatment